Print

Popular Diabetes Drug May Lower Prostate Cancer Risk, Harvard School of Public Health Study  
1/20/2014 6:53:38 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Higher levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest decreased risk for developing advanced prostate cancer, according to results presented here at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21. Melatonin is a hormone that is produced exclusively at night in the dark and is an important output of the circadian rhythm, or the body's inherent 24-hour clock.

Hey, check out all the research scientist jobs. Post your resume today!

//-->